{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:07:02Z","timestamp":1785434822648,"version":"3.56.0"},"reference-count":36,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"College of Medicine, MacKay Medical University, Taiwan","award":["MMC-RD-113-1C-P004"],"award-info":[{"award-number":["MMC-RD-113-1C-P004"]}]},{"name":"College of Medicine, MacKay Medical University, Taiwan","award":["MMC-RD-113-1E-P004"],"award-info":[{"award-number":["MMC-RD-113-1E-P004"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,11,27]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Evaluation of the impact of atherosclerotic cardiovascular disease (ASCVD), particularly polyvascular disease, on 30-day and 365-day mortality among intensive care unit (ICU) patients diagnosed with sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>This study was conducted using data from the Medical Information Mart for Intensive Care IV, a publicly available critical care database from a tertiary care hospital in the US.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 7895 adult ICU patients with sepsis were included between 2008 and 2022. Among them, 3314 (41.97%) had ASCVD, defined by International Classification of Diseases (ICD) codes for coronary artery disease, peripheral artery disease or stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>The primary outcomes were all-cause mortality at 30 and 365 days following ICU admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>ASCVD patients with a greater number of disease beds tend to be male, older, have lower body mass index, heart rates, mean blood pressure, respiratory rate and temperature, compared with non-ASCVD patients. Before propensity-score matching, patients with ASCVD (3314) had significantly higher 30-day (29.21% vs 24.14%, p&lt;0.001) and 365-day mortality (30.81% vs 25.67%, p&lt;0.001) compared with those without ASCVD (4581). Multivariate Cox regression analysis identified ASCVD as an independent predictor of 30-day (HR: 1.166, 95%\u2009CI 1.046 to 1.300, p=0.006), indicating a 16.6% higher risk of death within 30 days. For 365-day mortality, ASCVD patients had an HR of 1.168 (95% CI 1.051 to 1.298, p=0.004), reflecting a 16.8% increased risk of death within a year. Mortality risk increased incrementally with the number of involved vascular beds, especially in patients with three disease beds who exhibited the highest risk. Our findings reveal that in sepsis patients with ASCVD as a continuous variable, each additional bed increased the 30-day and 365-day mortality risk by 13.1% and 13.9%. ASCVD significantly increases the mortality risk in ICU patients with sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Integrated management of sepsis and ASCVD\u2014using targeted interventions such as tailored pharmacotherapy and risk factor modification\u2014may reduce mortality and morbidity in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-108713","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:05:58Z","timestamp":1765782358000},"page":"e108713","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of atherosclerotic cardiovascular disease on mortality in ICU sepsis patients: a retrospective MIMIC-IV cohort study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5022-6898","authenticated-orcid":false,"given":"Yu-Cheng","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan"},{"name":"Department of Cardiology, Asia University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-9676","authenticated-orcid":false,"given":"Min-I","family":"Su","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Medicine, MacKay Medical University, New Taipei City, Taiwan"},{"name":"Division of Cardiology, Department of Internal Medicine, Taitung MacKay Memorial Hospital, Taitung, Taiwan"},{"name":"Graduate Institute of Business Administration, College of Management, National Dong Hwa University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1826-7689","authenticated-orcid":false,"given":"Wen-Pin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8403-3656","authenticated-orcid":false,"given":"En-Chih","family":"Liao","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Medicine, MacKay Medical University, New Taipei City, Taiwan"},{"name":"Institute of Biomedical Sciences, MacKay Medical University, New Taipei City, Taiwan"},{"name":"Institute of Clinical Medicine, College of Medicine, MacKay Medical University, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"2026010703465790000_15.12.e108713.1","doi-asserted-by":"crossref","unstructured":"Amer M , M\u00f8ller MH , Granholm A , et al . A systematic methodological evaluation of sepsis guidelines: Protocol for quality assessment and consistency of recommendations. Acta Anaesthesiol Scand 2025;69. doi:10.1111\/aas.70036","DOI":"10.1111\/aas.70036"},{"key":"2026010703465790000_15.12.e108713.2","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-023-04762-6","article-title":"Targeting the host response in sepsis: current approaches and future evidence","volume":"27","author":"Bode","year":"2023","journal-title":"Crit Care"},{"key":"2026010703465790000_15.12.e108713.3","first-page":"40","article-title":"Pathogenesis of atherosclerosis: A multifactorial process","volume":"7","author":"Singh","year":"2002","journal-title":"Exp Clin Cardiol"},{"key":"2026010703465790000_15.12.e108713.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302721"},{"key":"2026010703465790000_15.12.e108713.5","article-title":"Comparative analysis of cardiogenic shock outcomes in acute myocardial infarction with polyvascular disease","volume":"46","author":"Gatuz","year":"2024","journal-title":"Am Heart J Plus"},{"key":"2026010703465790000_15.12.e108713.6","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-019-1178-6","article-title":"Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition","volume":"19","author":"Rosenblit","year":"2019","journal-title":"Curr Diab Rep"},{"key":"2026010703465790000_15.12.e108713.7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12272-019-01116-1","article-title":"Current pharmacotherapies for atherosclerotic cardiovascular diseases","volume":"42","author":"Park","year":"2019","journal-title":"Arch Pharm Res"},{"key":"2026010703465790000_15.12.e108713.8","first-page":"41","article-title":"The paradigm of immunosenescence in atherosclerosis-cardiovascular disease (ASCVD)","volume":"29","author":"Laderoute","year":"2020","journal-title":"Discov Med"},{"key":"2026010703465790000_15.12.e108713.9","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-09081-x","article-title":"Prevalence and outcomes of chronic comorbid conditions in patients with sepsis in Korea: a nationwide cohort study from 2011 to 2016","volume":"24","author":"Kang","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2026010703465790000_15.12.e108713.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.05.002"},{"key":"2026010703465790000_15.12.e108713.11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195782","article-title":"Biomarkers for the Prediction and Judgement of Sepsis and Sepsis Complications: A Step towards precision medicine?","volume":"11","author":"von Groote","year":"2022","journal-title":"J Clin Med"},{"key":"2026010703465790000_15.12.e108713.12","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31827e83af"},{"key":"2026010703465790000_15.12.e108713.13","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14010106","article-title":"Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making","volume":"14","author":"Ramasco","year":"2024","journal-title":"J Pers Med"},{"key":"2026010703465790000_15.12.e108713.14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1164\/rccm.202105-1322ED","article-title":"Identifying Survivors of Sepsis at Risk for Adverse Cardiovascular Outcomes","volume":"204","author":"Mayr","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026010703465790000_15.12.e108713.15","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31828e9863"},{"key":"2026010703465790000_15.12.e108713.16","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-014-0452-y"},{"key":"2026010703465790000_15.12.e108713.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100130","article-title":"Inflammation and cardiovascular disease: From mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am J Prev Cardiol"},{"key":"2026010703465790000_15.12.e108713.18","unstructured":"Johnson A , Bulgarelli L , Pollard T , et al . Mimic-iv. PhysioNet; 2020. Available: https:\/\/physionet org\/content\/mimiciv\/10\/ [Accessed 23 Aug 2021]."},{"key":"2026010703465790000_15.12.e108713.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"2026010703465790000_15.12.e108713.20","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.23.e215"},{"key":"2026010703465790000_15.12.e108713.21","doi-asserted-by":"crossref","unstructured":"Hofford MR , Yu SC , Johnson AEW , et al . OpenSep: a generalizable open source pipeline for SOFA score calculation and Sepsis-3 classification. JAMIA Open 2022;5. doi:10.1093\/jamiaopen\/ooac105","DOI":"10.1093\/jamiaopen\/ooac105"},{"key":"2026010703465790000_15.12.e108713.22","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-017-1012-y"},{"key":"2026010703465790000_15.12.e108713.23","first-page":"588","article-title":"Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention","volume":"94","author":"Ramzy","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026010703465790000_15.12.e108713.24","doi-asserted-by":"crossref","unstructured":"Gutierrez JA , Mulder H , Jones WS , et al . Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial. JAMA Netw Open 2018;1. doi:10.1001\/jamanetworkopen.2018.5239","DOI":"10.1001\/jamanetworkopen.2018.5239"},{"key":"2026010703465790000_15.12.e108713.25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2021.07.008","article-title":"Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry","volume":"339","author":"Jang","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026010703465790000_15.12.e108713.26","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57070701","article-title":"Recognized and Potentially New Biomarkers-Their Role in Diagnosis and Prognosis of Cardiovascular Disease","volume":"57","author":"Bargie\u0142","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"2026010703465790000_15.12.e108713.27","doi-asserted-by":"crossref","DOI":"10.3390\/cells13050439","article-title":"Advances and Challenges in Sepsis Management: Modern Tools and Future Directions","volume":"13","author":"Santacroce","year":"2024","journal-title":"Cells"},{"key":"2026010703465790000_15.12.e108713.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.01.081"},{"key":"2026010703465790000_15.12.e108713.29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: pathophysiology and management","volume":"4","author":"Kakihana","year":"2016","journal-title":"J Intensive Care"},{"key":"2026010703465790000_15.12.e108713.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.08.007"},{"key":"2026010703465790000_15.12.e108713.31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1396656","article-title":"Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026010703465790000_15.12.e108713.32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/14787210.2022.2040359","article-title":"Managing sepsis in the era of precision medicine: challenges and opportunities","volume":"20","author":"Watkins","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026010703465790000_15.12.e108713.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.10.011","article-title":"Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial","volume":"338","author":"Samsky","year":"2021","journal-title":"Atherosclerosis"},{"key":"2026010703465790000_15.12.e108713.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.059"},{"key":"2026010703465790000_15.12.e108713.35","doi-asserted-by":"crossref","unstructured":"Zheng P , Wang X , Guo T , et al . Cardiac troponin as a prognosticator of mortality in patients with sepsis: A systematic review and meta-analysis. Immun Inflamm Dis 2023;11. doi:10.1002\/iid3.1014","DOI":"10.1002\/iid3.1014"},{"key":"2026010703465790000_15.12.e108713.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2009.12.001"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-108713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:48:26Z","timestamp":1767786506000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-108713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,14]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2025-108713"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-108713","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}